197 related articles for article (PubMed ID: 28817184)
1. The Influence of Cytomegalovirus on Expression of HLA-G and its Ligand KIR2DL4 by Human Peripheral Blood Leucocyte Subsets.
Albayati Z; Alyami A; Alomar S; Middleton D; Bonnett L; Aleem S; Flanagan BF; Christmas SE
Scand J Immunol; 2017 Nov; 86(5):396-407. PubMed ID: 28817184
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
4. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G.
Djurisic S; Skibsted L; Hviid TV
Am J Reprod Immunol; 2015 Nov; 74(5):427-44. PubMed ID: 26293482
[TBL] [Abstract][Full Text] [Related]
5. Role of cytomegalovirus in the T cell changes seen in elderly individuals.
Looney RJ; Falsey A; Campbell D; Torres A; Kolassa J; Brower C; McCann R; Menegus M; McCormick K; Frampton M; Hall W; Abraham GN
Clin Immunol; 1999 Feb; 90(2):213-9. PubMed ID: 10080833
[TBL] [Abstract][Full Text] [Related]
6. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
[TBL] [Abstract][Full Text] [Related]
7. Increased numbers and functional activity of CD56⁺ T cells in healthy cytomegalovirus positive subjects.
Almehmadi M; Flanagan BF; Khan N; Alomar S; Christmas SE
Immunology; 2014 Jun; 142(2):258-68. PubMed ID: 24433347
[TBL] [Abstract][Full Text] [Related]
8. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
Abu-Khader A; Krause S
Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
[TBL] [Abstract][Full Text] [Related]
9. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.
Béziat V; Dalgard O; Asselah T; Halfon P; Bedossa P; Boudifa A; Hervier B; Theodorou I; Martinot M; Debré P; Björkström NK; Malmberg KJ; Marcellin P; Vieillard V
Eur J Immunol; 2012 Feb; 42(2):447-57. PubMed ID: 22105371
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
11. Significant IFNγ responses of CD8+ T cells in CMV-seropositive individuals with autoimmune arthritis.
Almanzar G; Schmalzing M; Trippen R; Höfner K; Weißbrich B; Geissinger E; Meyer T; Liese J; Tony HP; Prelog M
J Clin Virol; 2016 Apr; 77():77-84. PubMed ID: 26921739
[TBL] [Abstract][Full Text] [Related]
12. Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.
Muñoz-Cobo B; Solano C; Benet I; Costa E; Remigia MJ; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Bravo D; Clari MÁ; Navarro D
J Med Virol; 2012 Feb; 84(2):259-67. PubMed ID: 22170546
[TBL] [Abstract][Full Text] [Related]
13. NKG2C
Grutza R; Moskorz W; Senff T; Bäcker E; Lindemann M; Zimmermann A; Uhrberg M; Lang PA; Timm J; Cosmovici C
J Immunol; 2020 Jun; 204(11):2910-2917. PubMed ID: 32284334
[TBL] [Abstract][Full Text] [Related]
14. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
15. Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.
Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
J Immunol; 2014 Jan; 192(2):732-40. PubMed ID: 24337374
[TBL] [Abstract][Full Text] [Related]
16. CMV infection is associated with the depletion but lack of activation of peripheral blood natural killer cells in a lung transplant cohort.
Fildes JE; Walker AH; Williams SG; Yonan N; Leonard CT
Transpl Immunol; 2008 Jul; 19(3-4):235-7. PubMed ID: 18583135
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.
Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M
Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492
[TBL] [Abstract][Full Text] [Related]
18. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D
J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229
[TBL] [Abstract][Full Text] [Related]
19. Effect of age and CMV on NK cell subpopulations.
Campos C; Pera A; Sanchez-Correa B; Alonso C; Lopez-Fernandez I; Morgado S; Tarazona R; Solana R
Exp Gerontol; 2014 Jun; 54():130-7. PubMed ID: 24440462
[TBL] [Abstract][Full Text] [Related]
20. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
Lemmermann NA; Reddehase MJ
Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
